Encapsulation Platform for Cell Therapy

About Theracyte

TheraCyte is a private, early-stage biotechnology company focused on a platform technology for cell encapsulation and transplantation. Its core innovation is a biocompatible, membrane-based polymeric chamber that shields allogeneic cells from host immune attack and, upon subcutaneous implantation, becomes vascularized to support cell survival and function. The company currently generates early revenue by selling its encapsulation devices for research use while the technology is being developed by partners for therapeutic applications in diabetes and other chronic conditions. Its long-term goal is to enable off-the-shelf cell therapies without the need for chronic immunosuppression.

Therapeutic Areas